Mark Gurnell

Mark Gurnell, Professor of Clinical Endocrinology & Head of Section, University of Cambridge, Clinical Lead, Cambridge University Hospitals NHS Foundation Trust, Cambridge UK

Mark Gurnell is Professor of Clinical Endocrinology in Cambridge, where he is Clinical Lead for Endocrine Services. He is Head of Section (Specialty Medicine Research & Training) in the Department of Medicine, and SubDean in the School of Clinical Medicine, at the University of Cambridge. His clinical and research interests are focussed on pituitary, adrenal and thyroid disorders, including:
• acromegaly
• Cushing disease
• TSH-secreting pituitary adenomas
• secondary adrenal insufficiency
• primary aldosteronism

He is head of the Cambridge Endocrine Molecular Imaging Group (CEMIG) and has led the development of novel PET tracers for imaging pituitary adenomas and adrenocortical tumours, with several now adopted for use in routine clinical practice. He co-leads the Cambridge REFTFTs service, which provides advice on the investigation and management of patients with unusual/atypical thyroid function test results.

He serves on several national and international committees including:

• Council of the UK Society for Endocrinology (SfE) (as Treasurer)
• Education Committee of the European Society of Endocrinology (ESE)
• Pituitary Society’s Professional Education Committee

He currently holds several senior appointments in medical education, including:

• Chair, Executive Board of the UK Medical Schools Council Assessment Alliance (MSCAA)
• Chair, Exam Board, UK Medical Licensing Assessment (MLA) Applied Knowledge Test (AKT)
• Co-Chair, European Board Examination in Endocrinology, Diabetes & Metabolism (EBEEDM)